Why investors are flocking to Nordic life sciences

The 7th Life Science Investor Partnering Day in Oslo showed that investor interest in life science has never been stronger. We see seven trends driving this:

1. Uncertainty is pushing capital toward real-world solutions

Global instability is changing how investors think about risk and opportunity. More investors are looking toward sectors tied to fundamental needs: health, food, and the environment. At the same time, the Nordics stand out as a stable region with strong science, a high level of trust, and a broad pipeline of companies. This represents a clear opportunity for the region if we act on it.

2. Life science is preparedness

Preparedness and resilience are now firmly on the agenda. Life science plays a key role across health systems, food security, and environmental solutions. It is increasingly seen as part of critical infrastructure, not a niche sector.

3. Climate meets biology

Climate challenges are driving more attention toward biological solutions. Investment is expanding into areas like bioresources, animal health, and feed, where protecting ecosystems and building sustainable systems go hand in hand.

4. Impact is shaping capital and participation

Life sciences sit at the core of impact investing. Female founders and investors are more strongly represented in impact-focused industries than in other sectors and often prioritize these areas. A stronger impact ecosystem, with life sciences at the forefront, will also contribute to a more diverse investment landscape.

5. Food scarcity drives investment in agriculture and marine sectors

Among the 30+ investors participating in the 7th Life Science Investor Partnering Day, we saw increased representation from investors in the agriculture and marine sectors. Rising global demand for protein is putting these sectors at the top of the agenda, and with it we are seeing growing interest from both specialist and generalist investors.

Norway is exceptionally well positioned to meet this challenge.

Norway is exceptionally well positioned to meet this challenge. A dense ecosystem of suppliers, technology companies, and research institutions spans both sectors, underpinned by decades of operational excellence in aquaculture and agriculture. That heritage has produced world-recognized companies and a hard-won reputation that continues to attract international capital and seeds the next generation of innovation

6. Nordic companies are gaining global attention

Nordic life science companies are increasingly making their mark on the global stage. One striking example is the Norwegian company Oncoinvent, which is transforming cancer care through direct alpha therapy, currently securing patents for its Radspherin, a receptor-independent alpha radiation therapy, across major markets worldwide.

Norwegian Mycelium (NoMy) offers another: the company is gaining significant traction in Japan with its proprietary fungal fermentation technology. A third is Do More Diagnostics, which was recently selected by Hello Tomorrow as one of 100 global deep-tech startups to watch in 2026 – chosen from a pool of 4,800 applicants.

7. The Nordics is a shared market

The 7th Life Science Investor Partnering Day is a Nordic event, and that was reflected in the significant presence from the Nordic startup scene. The startups emerging from this ecosystem are increasingly thinking Nordic before they think Norwegian, Swedish, or Danish. Geography still shapes where companies are founded and where early capital comes from, but it is no longer the ceiling.

Geography still shapes where companies are founded and where early capital comes from, but it is no longer the ceiling.

The next generation of life science and deep-tech founders across Scandinavia are building with a shared market in mind from day one, drawing on cross-border talent, co-investing across borders, and recognizing that the distance between Oslo, Copenhagen, and Stockholm is far smaller than the challenges they are working to solve.